1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
Ectopic pregnancies are treated with Methotrexate 50 mg/m2 IM. We have a case where the patient who received this dose was breastfeeding an infant. How long should a patient wait before being allowed to resume breastfeeding after this single dose of IM Methotrexate?
The half life for Methotrexate is 8-15 hours. For breastfeeding, the general advice is that if less than 10% of the maternal weight adjusted dose passes into the milk, the medication is considered compatible for breastfeeding. With Methotrexate the relative infant dose indicated is 0.12% of the maternal dose, which is extremely negligible. However Methotrexate can be retained in human tissue particularly neonatal GI tissue and ovarian cells for months. With chronic exposure therefore the potential for hazard for the infant may increase as the dose accumulates in his/her body. It is advisable for the milk to be pumped and discarded for a minimum of four days before resuming breastfeeding.